Retinoblastoma
Retinoblastoma is a rare type of eye cancer that typically occurs in young children, affecting the retina and potentially leading to vision loss if not treated promptly.
Unilateral Retinoblastoma: Adjuvant Treatment Study
We are studying additional treatments for patients with unilateral retinoblastoma after eye removal. The goal is to understand how these treatments affect recovery and any potential side effects.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 2 months and 10 years old?
- Do you have a diagnosis of non-familial extensive unilateral retinoblastoma that was treated by removing the eye (enucleation)?
- Have you not received chemotherapy or radiotherapy for retinoblastoma or any other tumor before starting this study?
- Do you have any uncontrolled medical conditions that would prevent you from following the study rules?
- Do you have a family history of retinoblastoma (like bilateral or familial retinoblastoma)?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Carbo-Cell
Carbomedac
Carboplan
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire D'Angers
Unité d’Hématologie/Oncologie/Immunologie Pédiatrique
Angers, France
Centre Hospitalier Universitaire De Toulouse
Hémato-oncologie Pédiatrique
Blagnac, France
Centre Hospitalier Universitaire De Bordeaux
Pédiatrie
Bordeaux, France
Sponsor: Institut Curie
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.